MEDP stock forecast
Our latest prediction for Medpace Holdings, Inc.'s stock price was made on the Dec. 20, 2019 when the stock price was at 84.42$.
In the short term (2weeks), MEDP's stock price should underperform the market by -3.10%. During that period the price should oscillate between -5.94% and +4.09%.
In the medium term (3months), MEDP's stock price should underperform the market by -7.94%. During that period the price should oscillate between -18.56% and +11.82%.Get email alerts
About Medpace Holdings, Inc.
Medpace Holdings, Inc. is a contract research organization, which engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
At the moment the company generates 823M USD in revenues.
On its last earning announcement, the company reported a profit of 2.49$ per share.
The book value per share is 15.18$
Three months stock forecastDec. 20, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|